Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2010 Publisher: RenaCare NephroMed GmbH, Werrastr. 1 a, 35625 Hüttenberg, Germany Phone: +49 (0) 64 03 9 21 60 Fax: +49 (0) 64 03 9 21 63 E-mail: mail@renacare.com
Renacet 475 mg, film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. white, round, convex film-coated tablets. |
Active substance: Calcium acetate.
Each film-coated tablet contains:
475 mg calcium acetate (anhydrous) equivalent to 120.25 mg calcium.
Excipients: Contains sucrose, see section 4.4.
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Calcium acetate |
Calcium is an endogenous ion of the body essential for the maintenance of a number of physiologic processes. It participates as an integral factor in the maintenance of the functional integrity of the nervous system, in the contractile mechanisms of muscle tissue, in the clotting of blood, and in the formation of the major structural material of the skeleton. Soluble calcium salts are commonly used in the treatment of calcium deficiency. |
| List of Excipients |
|---|
|
Tablet core: Maize starch Film coat: Hypromellose |
Pack sizes:
100 film-coated tablets
200 film-coated tablets
PVDC-coated PVC/aluminium foil blisters
RenaCare NephroMed GmbH, Werrastr. 1 a, 35625 Hüttenberg, Germany
Phone: +49 (0) 64 03 9 21 60
Fax: +49 (0) 64 03 9 21 63
E-mail: mail@renacare.com
PL 36032/0001
30/06/2010
| Drug | Countries | |
|---|---|---|
| RENACET | Germany, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
